<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Thu, 23 Apr 2026 21:57:58 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/imbruvica/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[How Blood Cancer Is Diagnosed: Bone Marrow vs. Blood Tests]]></title><description><![CDATA[Accurate and timely diagnosis is crucial in the fight against blood cancers. Blood tests and bone marrow biopsies are essential tools in identifying these complex diseases. While blood tests provide an]]></description><link>http://direct.ecency.com/mrmed/@mrmed/how-blood-cancer-is-diagnosed</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/how-blood-cancer-is-diagnosed</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Fri, 21 Mar 2025 03:41:48 GMT</pubDate></item><item><title><![CDATA[Say Goodbye to Harsh Cancer Treatments!]]></title><description><![CDATA[The introduction of BTK inhibitors has transformed the treatment landscape for CLL, MCL, and WM, offering patients a more effective and tolerable alternative to traditional therapies. By specifically targeting]]></description><link>http://direct.ecency.com/mrmed/@mrmed/say-goodbye-to-harsh-cancer</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/say-goodbye-to-harsh-cancer</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Mon, 17 Mar 2025 04:42:06 GMT</pubDate></item><item><title><![CDATA[Blood Cancer Breakdown and their Types and Challenges]]></title><description><![CDATA[Blood cancer, or hematologic cancer, is a group of diseases that target the blood, bone marrow, and lymphatic system—critical components of our body’s defence and overall function. Unlike solid tumours,]]></description><link>http://direct.ecency.com/mrmed/@mrmed/blood-cancer-breakdown-and-their</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/blood-cancer-breakdown-and-their</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Thu, 06 Feb 2025 03:26:24 GMT</pubDate></item><item><title><![CDATA[How to use Imbruvica capsule and its side effects?]]></title><description><![CDATA[MCL (Mantle-cell lymphoma) and blood cancer (chronic lymphocytic leukemia) are treated with Imbruvica 140mg Capsule. It is also employed in chronic lymphocytic leukaemia who have received at least one]]></description><link>http://direct.ecency.com/mrmed/@mrmed/how-to-use-imbruvica-capsule</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/how-to-use-imbruvica-capsule</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Wed, 30 Nov 2022 08:13:48 GMT</pubDate></item></channel></rss>